Research at OnkPat
OnkPat consists of more than 30 research groups
18 OnkPat-researchers receives project funding from Swedish Cancer Society 2023.
Congratulations to all OnkPat-researchers who receives funding from the Swedish Cancer Society 2023! Lars Egevad, Simon Ekman, Martin Enge, Leonard Girnita och Weng-Onn Lui receives SEK 3 million each. Anita Göndör, Elham Hedayati, Rozbeh Jafari, Kasper Karlsson, Anders Näsman and Sean Rudd receives SEK 2,4 million each. Johan Hartman and Christofer Juhlin receives SEK 3,75 million each. Lars Holmgren, Tina Dalianis and Catharina Larsson receives SEK 4,5 million each. Sten Nilsson receives SEK 5,25 million and Janne Lehtiö SEK 6 million.
Karin Lindberg and Lisa Liu Burström receives research months and Gabriella Cohn Cedermark and Weng-Onn Lui receives SEK 600 000 and SEK 250 000 planning grants for SWENOTECA (Swedish Norwegian Testicular Cancer Project) and Nordic Merkel Cell Carcinoma Interest Group.
Eight OnkPat-researchers receives funding from the Swedish Research Council
In the call for 2023 from the Swedish Research Council, eight researchers from the Department of Oncology-Pathology receives funding. Martin Enge receives 3.6 million SEK, Kasper Karlsson 6 million SEK, Linda Sofie Lindström 4.8 million SEK, Kenny Rodriguez-Wallberg 3.6 million SEK, Susanne Schlisio 9 million SEK, Thuy Tran 4.8 million SEK, Stina Wickström 2.4 million SEK and Arne Östman 2.4 million SEK.
Two OnkPat researchers receives funding from Bröstcancerförbundet
Bröstcancerförbundet allocates 14 050 000 SEK to patient-oriented breast cancer research for 2023. Renske Altena receives 750 000 SEK and Fredrik Strand receives 1 000 000 SEK.
Quality of life in cancer patients
In 2000, Yvonne Brandberg and colleagues published Swedish norm data, divided by gender and age groups for a specific questionnaire (EORTC QLQ-C30) that is widely used in quality of life research in the field of cancer. Norm data are average values for a certain characteristic in a population and can be used to compare the results of individuals with the results of the population and see if they deviate from the norm. The interest in that article has been great and it has been cited 500 times. Now the group has published updated norm data showing that the quality of life generally does not differ much since 2000, except in the age group ≥70 years, who now report a higher quality of life regarding several variables. The results are published in Acta Oncologica.